U.S. Markets open in 6 hrs 15 mins

Top Ranked Momentum Stocks to Buy for November 8th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 8th:

CyberOptics Corporation (CYBE): This high precision sensing technology developing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

CyberOptics Corporation Price and Consensus

CyberOptics Corporation Price and Consensus

CyberOptics Corporation price-consensus-chart | CyberOptics Corporation Quote

CyberOptics’ shares gained nearly 30% over the last one month above the S&P 500’s increase 6.6%. The company possesses a Momentum Score of A.

CyberOptics Corporation Price

CyberOptics Corporation Price

CyberOptics Corporation price | CyberOptics Corporation Quote

EverQuote, Inc. (EVER): This online marketplace for insurance shopping has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 37% over the last 60 days.

EverQuote, Inc. Price and Consensus

EverQuote, Inc. Price and Consensus

EverQuote, Inc. price-consensus-chart | EverQuote, Inc. Quote

EverQuote’s shares gained 52.8% over the last one month. The company possesses a Momentum Score of A.

EverQuote, Inc. Price

EverQuote, Inc. Price

EverQuote, Inc. price | EverQuote, Inc. Quote

InMode Ltd. (INMD): This minimally-invasive aesthetic medical products development company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.3% over the last 60 days.

InMode Ltd. Price and Consensus

InMode Ltd. Price and Consensus

InMode Ltd. price-consensus-chart | InMode Ltd. Quote

InMode’s shares gained 80.9% over the last one month. The company possesses a Momentum Score of A.

InMode Ltd. Price

InMode Ltd. Price

InMode Ltd. price | InMode Ltd. Quote

Moderna, Inc. (MRNA): This clinical stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

Moderna, Inc. Price and Consensus

Moderna, Inc. Price and Consensus

Moderna, Inc. price-consensus-chart | Moderna, Inc. Quote

Moderna’s shares gained 14.3% over the last one month. The company possesses a Momentum Score of A.

Moderna, Inc. Price

Moderna, Inc. Price

Moderna, Inc. price | Moderna, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Moderna, Inc. (MRNA) : Free Stock Analysis Report
 
InMode Ltd. (INMD) : Free Stock Analysis Report
 
EverQuote, Inc. (EVER) : Free Stock Analysis Report
 
CyberOptics Corporation (CYBE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research